In April, when associate research scientist in epidemiology Anne Wyllie and her team at Yale released a potentially seminal preprint on saliva testing for SARS-CoV-2, their inboxes exploded. Their results suggested that using saliva samples could be more sensitive than results from the widely used nasopharyngeal (NP) swabs.